Status:
UNKNOWN
Developing a Model to Better Predict Diabetes and/or Risk of Developing Diabetes
Lead Sponsor:
Viome
Conditions:
Diabetes Type 2
Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Participants who were previously Viome costumers who signed informed consent to participate and self reported type 2 diabetes or pre-diabetes were enrolled. They provided stool samples to VIOME and we...
Eligibility Criteria
Inclusion
- Viome customer
- GI test collected at home using Viome test kit
- US citizen
- 18+ years old
- Is not participating in any other Viome study
- Must have answered the following on-boarding question with the indicated answer:
- "Do you or did you ever have diabetes or prediabetes?"
- Signed and dated informed consent prior to any trial-specific procedures are performed
- Able to speak and read English
- Willing and able to follow the trial instructions
Exclusion
- Unable/unwilling to complete the informed consent form and the questionnaires
Key Trial Info
Start Date :
May 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
2912 Patients enrolled
Trial Details
Trial ID
NCT04905485
Start Date
May 21 2021
End Date
December 31 2023
Last Update
June 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Viome Research Institute
Bothell, Washington, United States, 98011